摘要
摘要目的探讨厄贝沙坦与依那普利对原发性高血压的不同干预作用并对其疗效进行对比与评价.方法将原发性高血压患者９２例随机分为试验组、对照组,每组各４６例,试验组予以厄贝沙坦进行干预治疗,对照组均予以依那普利,比较两组患者的治疗效果.结果试验组患者的治疗效果等指标均优于经依那普利干预的对照组,差异具有统计学意义(P＜０??０５).结论厄贝沙坦和依那普利都可以有效降低原发性高血压患者血压,一定程度上逆转左心室肥厚并改善左心室舒张功能,临床效果好,但相对而言厄贝沙坦临床效果更明显,值得临床深入推广.关键词厄贝沙坦;依那普利;原发性高血压;临床疗效EvaluationofirbesartanandBeaKnappLeighontheeffectofprimaryhypertensionTANyuegui,GAOYing,LIxinpei,SUNzhonghuiDUANhaijie,WANGYou(Xi’anNO??５Hospital,Xi’an７１００８２,China)AbstractObjectiveToinvestigatetheeffectofdifferentinterventionofirbesartanandBeaKnappLeighinpatientswithhypertensionandcomparedwiththeealuＧationofitscurativeeffect??MethodsThe９２patientswithessentialhypertensionwererandomlydividedintoexperimentalgroupandcontrolgroup,４６casesineachgroup,thetestgroupreceivedirbesartantherapeuticinterventionandcontrolgroupsweretobeenalapril,twogroupswerecomparedtreatmenteffect??ResultsTreatＧmentandotherexperimentalgrouppatientswerebetterthanenalaprilinterventionbythecontrolgroup,thedifferencewasstatisticallysignificant(P＜０??０５)??ConclusionIrbesartanandenalaprilcaneffectivelyreducetheprimaryhypertension,degreeofreverseleftventricularhypertrophyandimproveleftventriculardiastolicfunctionandclinicaleffectofgood,butrelativelyspeakingirbesartanclinicaleffectmoreobvious,worthyoffurtherclinicalpromotion??
出版日期
2015年12月22日（中国期刊网平台首次上网日期，不代表论文的发表时间）
